SELEXIPAG for Pulmonary veno-occlusive disease: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where SELEXIPAG was used for Pulmonary veno-occlusive disease.
Most Reported Side Effects for SELEXIPAG
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Headache | 5,693 | 30.8% | 602 | 2,602 |
| Diarrhoea | 4,341 | 23.5% | 608 | 2,163 |
| Dyspnoea | 3,705 | 20.1% | 688 | 2,464 |
| Nausea | 3,392 | 18.4% | 387 | 1,699 |
| Pain in jaw | 2,072 | 11.2% | 189 | 961 |
| Fatigue | 2,009 | 10.9% | 246 | 1,085 |
| Death | 1,893 | 10.3% | 1,892 | 825 |
| Pain | 1,870 | 10.1% | 184 | 901 |
| Pain in extremity | 1,797 | 9.7% | 200 | 856 |
| Dizziness | 1,796 | 9.7% | 187 | 997 |
| Myalgia | 1,778 | 9.6% | 185 | 846 |
| Vomiting | 1,579 | 8.6% | 191 | 906 |
| Malaise | 1,511 | 8.2% | 210 | 875 |
| Hypotension | 1,392 | 7.5% | 321 | 928 |
| Pulmonary arterial hypertension | 1,387 | 7.5% | 712 | 917 |
Other Indications for SELEXIPAG
Pulmonary arterial hypertension (11,861)
Product used for unknown indication (3,685)
Pulmonary hypertension (2,500)
Connective tissue disorder (52)
Portopulmonary hypertension (35)
Heritable pulmonary arterial hypertension (19)
Systemic scleroderma (19)
Right-to-left cardiac shunt (18)
Heart disease congenital (9)
Condition aggravated (6)
Other Drugs Used for Pulmonary veno-occlusive disease
TREPROSTINIL (22)
EPOPROSTENOL (20)
AMBRISENTAN (17)
SILDENAFIL (14)
IMATINIB (13)
MACITENTAN (11)
DEFIBROTIDE (8)
BOSENTAN (5)
TADALAFIL (5)